ITCHY SKIN

Alleviating Itch, One of the Most Common Symptoms in Dermatology

Pruritus, the medical term for itch, is the uncomfortable sensation leading to the desire to scratch. Itch is one of the most common skin complaints, driving more than 7 million doctor's office visits in the United States every year. While everyone experiences occasional itching, chronic pruritus is defined as itch that persists for six weeks or longer. Unlike a brief itch from a bug bite or a rash that may clear on its own, chronic itch is a complex condition that can stem from many different sources, including skin conditions like eczema, psoriasis, or contact dermatitis; underlying health issues affecting the kidneys, liver, or thyroid; nerve damage or nerve dysfunction; emotional stress; or a combination of causes that can be difficult to untangle.1,2,3,4

Itch may seem straightforward, but the way the body produces and processes it is surprisingly complex. When the skin is exposed to an irritant, allergen, or inflammatory signal, specialized nerve endings just beneath the skin's surface detect those signals and send an "itch message" up through the nervous system to the brain, where the urge to scratch is triggered. While some people may assume that itch is always caused by histamine, the chemical behind hay fever and hives, histamine is only responsible for a small portion of chronic itch. For many patients, especially those with inflammatory skin conditions, itch is driven by immune proteins in the body that directly stimulate itch-sensing nerves and keep the itch signal going. This creates what is known as the itch-scratch cycle: scratching brings short-term relief but damages the skin further, which releases more itch-triggering signals, which causes more scratching, making the condition progressively harder to control. Over time, the nervous system can become so sensitized to these signals that it amplifies the sensation of itch even in the absence of a clear trigger.5,6,7
The impact of chronic itch on daily life is significant and often goes far beyond physical discomfort. Research shows that persistent itching disrupts sleep, makes it hard to concentrate, limits everyday activities, and takes a serious emotional toll, with strong links to anxiety and depression. Studies have found that nearly 1 in 5 patients living with chronic itch report thoughts of suicide, underscoring just how deeply this condition can affect a person's overall well-being.2,4,8

POTENTIAL TREATMENT

EURAX® is a prescription medicine used for eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin. Do not apply EURAX topically to patients who develop sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.

References:
  1. Shive, M., Linos, E., Berger, T., Wehner, M., & Chren, M. M. (2013). Itch as a patient-reported symptom in ambulatory care visits in the United States. Journal of the American Academy of Dermatology 69(4), 550–556.
    https://doi.org/10.1016/j.jaad.2013.05.029
  2. Whang, K. A., Khanna, R., Williams, K. A., Mahadevan, V., Semenov, Y., & Kwatra, S. G. (2021). Health-Related QOL and Economic Burden of Chronic Pruritus. The Journal of Investigative Dermatology, 141(4), 754–760.e1.
    https://doi.org/10.1016/j.jid.2020.08.020
  3. Weisshaar E, Matterne U. Epidemiology of Itch. In: Carstens E, Akiyama T, editors. Itch: Mechanisms and Treatment.
    Boca Raton (FL): CRC Press/Taylor & Francis; 2014. Chapter 2. Available from:
    https://www.ncbi.nlm.nih.gov/books/NBK200924/
  4. Roh, Y. S., Choi, J., Sutaria, N., & Kwatra, S. G. (2022). Itch: Epidemiology, clinical presentation, and diagnostic workup. Journal of the American Academy of Dermatology, 86(1), 1–14.
    https://doi.org/10.1016/j.jaad.2021.07.076
  5. Misery, L., Pierre, O., Le Gall-Ianotto, C., Lebonvallet, N., Chernyshov, P. V., Le Garrec, R., & Talagas, M. (2023). Basic mechanisms of itch. The Journal of Allergy and Clinical Immunology, 152(1), 11–23.
    https://doi.org/10.1016/j.jaci.2023.05.004
  6. Coscarella, G., Edwards, E., & Yosipovitch, G. (2026). Basic mechanisms of itch and advances in clinical management. Annals of Allergy, Asthma & Immunology : official publication of the American College of Allergy, Asthma, & Immunology, 136(2), 131–140.
    https://doi.org/10.1016/j.anai.2025.09.014
  7. Mack, M. R., & Kim, B. S. (2018). The Itch-Scratch Cycle: A Neuroimmune Perspective. Trends in Immunology, 39(12), 980–991.
    https://doi.org/10.1016/j.it.2018.10.001
  8. Criado, P. R., Jardim Criado, R. F., Ianhez, M., & Miot, H. A. (2025). Chronic pruritus: a narrative review. Anais Brasileiros de Dermatologia.
    https://doi.org/10.1016/j.abd.2024.09.008
 

IMPORTANT SAFETY INFORMATION

INDICATIONS AND USAGE:

For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.

SUMMARY OF RISK INFORMATION FOR EURAX CREAM

CONTRAINDICATIONS:

Do not apply EURAX topically to patients who develop sensitivity, are allergic to it, or manifest a primary irritation response to topical medications.

WARNINGS:

Discontinue treatment with this product if severe irritation or sensitization develops, and institute appropriate therapy.

PRECAUTIONS:

Do not apply EURAX in the eyes or mouth because it may cause irritation. Do not apply on acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided. It is not known whether EURAX can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. EURAX should be given to a pregnant woman only if clearly needed.

PRECAUTIONS:

Safety and effectiveness in pediatric patients have not been established. Clinical studies with EURAX did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects.

ADVERSE REACTIONS:

Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients. This preparation is not for ophthalmic, oral, or intravaginal use.
To report SUSPECTED ADVERSE REACTIONS, contact Journey Medical Corporation at 1-855-531-1859 or FDA at www.fda.gov/medwatch or call 1-800-FDA-1088. For topical use only. Please see Full Prescribing Information .